Gene Sequencing Robots: Top 7 Options in the USA for 2026

The NovaSeq X Plus is Illumina's market-leading high-throughput short-read sequencing robot, delivering unmatched raw throughput and very low cost-per-genome for large-scale gene sequencing robot deployments. Compared with Oxford Nanopore's long-read PromethION and portable MinION it prioritizes short-read accuracy and scale economics, and while MGI and Element can be more price-competitive in some regions the NovaSeq X Plus remains the go-to choice for centers that need maximum throughput and the broadest ecosystem support.

The PacBio Revio is a cutting-edge long-read sequencing system that offers unprecedented accuracy and throughput for complex genomic applications. With its innovative chip technology, the Revio enables researchers to generate high-quality data in a fraction of the time compared to traditional methods. Its unique SMRT sequencing technology ensures comprehensive genome coverage, making it a preferred choice for de novo genome assemblies and structural variant analysis. By merging throughput with quality, the Revio stands out among its competitors in the long-read sequencing arena.

The PromethION 2 Solo is Oxford Nanopore's high-capacity long-read sequencing robot optimized for large structural-variant, epigenetics and de novo assembly workflows with real-time basecalling and scalable flow-cell modules. Its ability to produce ultra-long reads and stream data live gives technical advantages over short-read systems like NovaSeq, MGI and Element for complex genomes, making it a complementary leader for labs that prioritize long-read capabilities over pure per-base short-read throughput.

The DNBSEQ-G99 from MGI Tech uses DNA nanoball chemistry to offer high-throughput short-read sequencing with competitive per-gigabase costs and low duplication rates, making it attractive for price-sensitive large projects and national sequencing initiatives. Financially it can undercut some Illumina offerings on reagent costs in select markets and is technically competitive for routine variant calling, though it typically lacks Illumina's global service footprint and the long-read advantages of Oxford Nanopore platforms.

The MiSeq i100 Series is Illumina's compact benchtop sequencing robot designed for rapid, low-cost runs and straightforward robotic integration for targeted panels and small labs. It offers much lower capital and per-run costs than large machines like the NovaSeq X Plus and is more appropriate than mid-throughput systems for low-volume clinical or research workflows, but it cannot match the high throughput or per-sample economics achievable on larger short-read or long-read platforms.

The MinION Mk1D is Oxford Nanopore's pocket-sized, field-deployable sequencing robot that enables real-time long-read sequencing with minimal capital expenditure, ideal for on-site pathogen surveillance and rapid prototyping of gene sequencing workflows. It uniquely enables mobile, low-overhead sequencing that none of the larger lab systems can match, though users trade off throughput, flow-cell lifespan and raw per-base accuracy versus benchtop and high-throughput instruments from Illumina, MGI and Element.